Here's Why Henry Schein (HSIC) is a Strong Value Stock

Group 1 - The Zacks Style Scores are complementary indicators that help investors select stocks with the best chances of outperforming the market over the next 30 days [2] - Each stock is rated from A to F based on value, growth, and momentum qualities, with A being the highest score indicating a better chance of outperforming [3] - The Value Score focuses on identifying undervalued stocks using ratios like P/E, PEG, and Price/Sales [4] Group 2 - The Growth Score assesses a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow [5] - The Momentum Score identifies optimal times to invest based on price trends and earnings estimate changes [6] - The VGM Score combines all three Style Scores, providing a comprehensive indicator for stock selection [7] Group 3 - The Zacks Rank is a proprietary stock-rating model that utilizes earnings estimate revisions to aid in portfolio creation [8] - Stocks rated 1 (Strong Buy) have produced an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal success [9] Group 4 - Henry Schein Inc. is a leading distributor of health care products and services, operating in 33 countries [11] - The company currently holds a Zacks Rank of 3 (Hold) with a VGM Score of B and a Value Style Score of A, indicating attractive valuation metrics [12] - For fiscal 2024, the Zacks Consensus Estimate for Henry Schein's earnings has increased to $5.08 per share, with an average earnings surprise of 2.6% [12]